Article info
ABSTRACT: Poster Session 1: Ovarian – Sunday, October 15, 2006
0099: Analysis of Gemcitabine As Second or Third Line Therapy for Recurrent Ovarian Cancer or Primary Peritoneal Cancer
Citation
0099: Analysis of Gemcitabine As Second or Third Line Therapy for Recurrent Ovarian Cancer or Primary Peritoneal Cancer
Online issue publication
December 17, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2006 IGCS, International Journal of Gynecological Cancer